0.68 - 0.75
0.33 - 0.86
13.79M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-29.45%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-61.53%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-496.72%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-496.72%
Negative operating income growth while 0335.HK is at 738.41%. Joel Greenblatt would press for urgent turnaround measures.
-64.24%
Negative net income growth while 0335.HK stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-27.12%
Negative EPS growth while 0335.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-27.12%
Negative diluted EPS growth while 0335.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
29.22%
Slight or no buybacks while 0335.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
29.28%
Diluted share change of 29.28% while 0335.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Dividend reduction while 0335.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.10%
Negative OCF growth while 0335.HK is at 108.55%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-2.79%
Negative FCF growth while 0335.HK is at 108.62%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-48.70%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-49.30%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-53.69%
Negative 3Y CAGR while 0335.HK stands at 10.12%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-963.10%
Negative 10Y OCF/share CAGR while 0335.HK stands at 468.30%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-956.34%
Negative 5Y OCF/share CAGR while 0335.HK is at 161.05%. Joel Greenblatt would question the firm’s operational model or cost structure.
-34.05%
Negative 3Y OCF/share CAGR while 0335.HK stands at 29.03%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-208.22%
Negative 10Y net income/share CAGR while 0335.HK is at 5529.72%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-514.36%
Negative 5Y net income/share CAGR while 0335.HK is 441.92%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-282.74%
Negative 3Y CAGR while 0335.HK is 7231.89%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
135.21%
10Y equity/share CAGR at 75-90% of 0335.HK's 152.58%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
-6.80%
Negative 5Y equity/share growth while 0335.HK is at 22.22%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-26.90%
Negative 3Y equity/share growth while 0335.HK is at 12.10%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 0335.HK stands at 14.28%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-5.13%
Firm’s AR is declining while 0335.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
22.07%
Inventory growth well above 0335.HK's 0.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
9.37%
Asset growth above 1.5x 0335.HK's 0.94%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-26.90%
We have a declining book value while 0335.HK shows 0.55%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
73.53%
We have some new debt while 0335.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-37.45%
Our R&D shrinks while 0335.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-33.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.